Outcomes of Antiretroviral Treatment: A Comparison Between Hospitals and Health Centers in Ethiopia

Abstract

Objective: The objective of this study was to compare the outcomes of antiretroviral therapy (ART) between hospital and health center levels in Ethiopia. Methods: Medical records of 1709 ART patients followed for 24 months at 2 hospitals and 3 health centers in the Oromia region of Ethiopia were reviewed. Noted outcomes of ART were currently alive and on treatment; lost to follow-up (LTFU); transferred out (TO); and died (D). Results: Of 1709 HIV-positive patients started on ART between September 2006 and February 2007, 1044 (61%) remained alive and were on treatment after 24-month follow-up. In all, 835 (57%) of ART patients at hospitals and 209 (83%) at health centers were retained in the program. Of those who were alive and receiving ART, 79% of patients at health centers and 72% at hospitals were clinically or immunologically improving. In addition, 331 (23%) patients at hospitals were LFTU as compared to 24 (10%) of patients at health centers (relative risk [RR] at 95% confidence interval [CI]: .358 [.231-.555]). While 11% was the mortality rate at hospitals, 5% of patients at health centers also died (RR at 95% CI: .360 [.192-.673]). Conclusion: Antiretroviral therapy at health centers was associated with more favorable outcomes than at hospitals.

Keywords

ART outcomes comparison Ethiopia

References

Unaids. Report on the Global AIDS Epidemic . Geneva: Joint United Nations Programme on AIDS; 2008. http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2007/default.asp. Accessed October 2, 2008.

Van Damme V. , Kegels G. Health system strengthening and scaling up antiretroviral therapy: the need for context-specific delivery models: comment on Schneider et al. Reprod Health Matters . 2006;14(27):24-26.

Koenig SP , Riviere C. , Leger P. , et al. The cost of antiretroviral therapy in Haiti. Cost Eff Resour Alloc. 2008;6:3.

Severe P. , Leger P. , Charles M. , et al. Antiretroviral therapy in a thousand patients with AIDS in Haiti . N Engl J Med. 2005; 353(22):2325-2334.

Castro A. Adherence to antiretroviral therapy: merging the clinical and social course of AIDS. PLoS Med. 2005;2(2):e338.

Kim YJ , Ammann A.

Is the ‘‘3 by 5’’ initiative the best approach to tackling the HIV pandemic?

PLoS Med. 2004 ;1(2):e37.

Hladik W. , Shabbir I. , Jelaludin A. , Woldu A. , Tsehaynesh M. , Tadesse W. HIV/AIDS in Ethiopia: where is the epidemic heading? Sex Transm Infect. 2006;82(suppl 1):132-135.

Fmoh. AIDS in Ethiopia 6th Report. Addis Ababa: Author; 2006. http://www.etharc.org. Accessed September 28, 2008 .

Deribe K. , Hailekiros F. , Biadgilign S. , Amberbir A. , Beyene BK Defaulters from antiretroviral treatment in Jimma University Specialized Hospital, Southwest Ethiopia. Trop Med Int Health. 2008 ;13(3):328-333.

10.

Who. Scaling Up Antiretroviral Therapy in Resource-Limited Settings: Treatment Guidelines for a Public Health Approach; 2003. Geneva: World Health Organization. http://www.who.int/hiv/pub/prev_care/en/arvrevision2003en.pdf . Accessed September 28, 2008.

11.

Loewenson R. , McCoy D. Access to antiretroviral treatment in Africa . BMJ. 2004;328(7434):241-242.

12.

Rosen S. , Ketlhapile M. , Sanne I. , DeSilva MB Cost to patients of obtaining treatment for HIV/AIDS in South Africa . S Afr Med J. 2007;97(7):524-529.

13.

McCoy D. , Chopra M. , Loewenson R. , et al. Expanding access to antiretroviral therapy in sub-Saharan Africa: avoiding the pitfalls and dangers, capitalizing on the opportunities. Am J Public Health . 2005;95(1):18-22.

14.

Bedelu M. , Ford N. , Hiderbrand K. , Reuter H. Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care. J Infect Dis. 2007;196(suppl 3): S464-S468.

15.

Rosen S. , Long L. , Sanne I. The outcomes and outpatient costs of different models of antiretroviral treatment delivery in South Africa. Trop Med Int Health. 2008;13(8):1005-1015.

16.

Boulle A. , Peter Bock P. , Osler M. , et al. Antiretroviral therapy and early mortality in South Africa. Bull World Health Organ. 2008; 86(9):678-687.

17.

Fmoh. Guidelines for Implementation of the Antiretroviral Therapy Programme in Ethiopia. Addis Ababa: Author; 2007. http://www.etharc.org/arvinfo/ethARTguideline_2007.pdf. Accessed November 28, 2008.

18.

Fmoh Guidelines for Management of Opportunistic Infections and Anti Retroviral Treatment in Adolescents and Adults in Ethiopia. Addis Ababa: Federal Ministry of Health; 2007. http://www.etharc.org/publications/oi_art_guideline.pdf . Accessed November 28, 2008.

19.

Stringer JS , Zulu I. , Levy J. , et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia feasibility and early outcomes. JAMA. 2006;296(7):782-793.

20.

Fmoh. Monthly HIV Care and ART Update. Addis Ababa: Author ; 2008. http://www.etharc.org . Accessed October 11, 2008.

21.

Marston BJ , Macharia DK , Nga’nga L. , et al. A program to provide antiretroviral therapy to residents of an urban slum in Nairobi, Kenya. J Int Assoc Physicians AIDS Care (Chic Ill). 2007; 6(2):106-112.

22.

Hosseinipour MC , Neuhann FH , Kanyama CC , et al. Lessons learned from a paying antiretroviral therapy service in the public health sector at Kamuzu Central Hospital, Malawi: 1-year experience. J Int Assoc Physicians Aids Care ( Chic Ill). 2006;5(3): 103-108.

23.

Sieleunou I. , Souleymanou M. , Schönenberger AM Determinants of survival in AIDS patients on antiretroviral therapy in a rural centre in the far-north province, Cameroon. Trop Med Int Health. 2009 ;14(1):36-43.